Syndax is a clinical-stage biopharmaceutical company developing epigenetic therapies to treat cancer, focused on addressing areas of high unmet medical need.
Syndax is a clinical-stage biopharmaceutical company developing epigenetic therapies to treat cancer, focused on addressing areas of high unmet medical need.